A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease
Titel:
A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease
Auteur:
McKerracher, Lisa Shenkar, Robert Abbinanti, Matthew Cao, Ying Peiper, Amy Liao, James K. Lightle, Rhonda Moore, Thomas Hobson, Nicholas Gallione, Carol Ruschel, Joerg Koskimäki, Janne Girard, Romuald Rosen, Kenneth Marchuk, Douglas A. Awad, Issam A.